XML 19 R8.htm IDEA: XBRL DOCUMENT
v3.22.1

Basis of Presentation | 3 Months Ended
--- | ---
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Basis of Presentation | Basis of Presentation Encompass Health Corporation, incorporated in Delaware in 1984, including its subsidiaries, is a leading provider of post-acute healthcare services, offering both facility-based and home-based patient services in 42 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies. We manage our operations and disclose financial information using two reportable segments: (1) inpatient rehabilitation and (2) home health and hospice. See also Note 11, Segment Reporting. On December 9, 2020, we announced a formal process to explore strategic alternatives for our home health and hospice business. As a result of this process, we expect to spin off our home health and hospice business to form an independent, publicly traded company on July 1, 2022, subject to customary conditions, including the effectiveness of a Form 10 registration statement, regulatory approvals and receipt of a favorable IRS private letter ruling. On January 19, 2022, we announced the home health and hospice business would be rebranded and operate under the name Enhabit Home Health & Hospice. The rebranding of agency locations began in mid-April 2022 and is expected to be largely completed by the effective date of the spin off. The accompanying unaudited condensed consolidated financial statements of Encompass Health Corporation and Subsidiaries should be read in conjunction with the consolidated financial statements and accompanying notes contained in Encompass Health’s Annual Report on Form 10-K filed with the United States Securities and Exchange Commission on February 25, 2022 (the “2021 Form 10‑K”). The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the SEC applicable to interim financial information. Certain information and note disclosures included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America have been omitted in these interim statements, as allowed by such SEC rules and regulations. The condensed consolidated balance sheet as of December 31, 2021 has been derived from audited financial statements, but it does not include all disclosures required by GAAP. However, we believe the disclosures are adequate to make the information presented not misleading. The unaudited results of operations for the interim periods shown in these financial statements are not necessarily indicative of operating results for the entire year. In our opinion, the accompanying condensed consolidated financial statements recognize all adjustments of a normal recurring nature considered necessary to fairly state the financial position, results of operations, and cash flows for each interim period presented. Certain prior-year amounts have been reclassified to conform to the current year presentation. Net Operating Revenues— Our Net operating revenues disaggregated by payor source and segment are as follows (in millions):
| Inpatient Rehabilitation |  | Home Health and Hospice |  | Consolidated
| Three Months Ended March 31, |  | Three Months Ended March 31, |  | Three Months Ended March 31,
| 2022 |  | 2021 |  | 2022 |  | 2021 |  | 2022 |  | 2021
Medicare | $ | 689.9 |  |  | $ | 614.5 |  |  | $ | 217.4 |  |  | $ | 223.9 |  |  | $ | 907.3 |  |  | $ | 838.4 |
Medicare Advantage | 156.0 |  |  | 158.4 |  |  | 34.5 |  |  | 28.0 |  |  | 190.5 |  |  | 186.4 |
Managed care | 131.5 |  |  | 112.2 |  |  | 18.8 |  |  | 14.3 |  |  | 150.3 |  |  | 126.5 |
Medicaid | 41.7 |  |  | 39.0 |  |  | 3.5 |  |  | 3.8 |  |  | 45.2 |  |  | 42.8 |
Other third-party payors | 10.1 |  |  | 12.1 |  |  | — |  |  | — |  |  | 10.1 |  |  | 12.1 |
Workers’ compensation | 6.1 |  |  | 5.7 |  |  | 0.1 |  |  | 0.1 |  |  | 6.2 |  |  | 5.8 |
Patients | 5.2 |  |  | 4.9 |  |  | — |  |  | 0.2 |  |  | 5.2 |  |  | 5.1 |
Other income | 18.8 |  |  | 13.1 |  |  | — |  |  | 0.2 |  |  | 18.8 |  |  | 13.3 |
Total | $ | 1,059.3 |  |  | $ | 959.9 |  |  | $ | 274.3 |  |  | $ | 270.5 |  |  | $ | 1,333.6 |  |  | $ | 1,230.4 |
See Note 1, Summary of Significant Accounting Policies, to the consolidated financial statements accompanying the 2021 Form 10-K for our policy related to Net operating revenues. Recently Adopted Accounting Pronouncements— We do not believe any recently issued, but not yet effective, accounting standards will have a material effect on our condensed consolidated financial position, results of operations, or cash flows.

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -URI http://asc.fasb.org/topic&trid=2122149 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -URI http://asc.fasb.org/topic&trid=2197479 + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration